Hydroxychloroquine in psoriasis: Is it really harmful? [3]

Acta Dermato-Venereologica

Volumn 86, Issue 5, 2006, Pages 450-451

  Sorbara, Stefania ^a   Cozzani, Emanuele ^a   Rebora, Alfredo ^a   Parodi, Aurora ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

AGED; ANAMNESIS; ARTHRALGIA; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; FEMALE; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSORIASIS; RADIOGRAPHY; RHEUMATOID ARTHRITIS; SKIN LUPUS ERYTHEMATOSUS;

AGED; ANTIMALARIALS; ARTHRALGIA; FEMALE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, CUTANEOUS; PSORIASIS;

EID: 33749009724     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0141     Document Type: Letter

References (13)

1. Cornbleet T. Action of synthetic antimalarial drugs on psoriasis. J Invest Dermatol 1956; 26: 435-436.
2. Lotem M, Ingber A, Segal R, Sandbank M. Generalized pustular drug rash induced by hydroxychloroquine hydroxychloroquine. Acta Derm Venereol 1990; 70: 250-251.
3. Slagel GA, James WD. Plaquenil-induced erythroderma. J Am Acad Dermatol 1985; 12: 857-862.
4. Vine JE, Hymes SR, Warner NB, Cohen PR. Pustular psoriasis induced by hydroxychloroquine: a case report and review of the literature. J Dermatol 1996; 23: 257-261.
5. Poljack M, Begenesic M, Duran V, Matovic L, Matic M, Janovic M, et al. Psoriasis and autoimmune skin disorders. Med Pregl 2002; 55: 325-328.
6. Millens JL, Muller SA. The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases. Arch Dermatol 1980; 116: 658-663.
7. Hays SB, Camisa C, Luzar MJ. The coexistence of lupus erythematosus and psoriasis. J Am Acad Dermatol 1984; 10: 619.
8. Zalla MJ, Muller SA. The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders. Acta Derm Venereol Suppl 1996; 195: 1-15.
9. Roenigk HH, Fowler-Bergfeld W, Curtis GH. Methotrexate for psoriasis in weekly oral doses. Arch Dermatol 1969; 99: 86-93.
10. Pantoja L, Gonzales-Lopez MA, Bouso M, Alija A, Ortiz-Saracho J. Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis. Scand J Rheumatol 2002; 31: 377-379.
11. Wolf R, Lo Schiavo A, Lombardi ML, De Angelis F, Ruocco V. The in vitro effect of hydroxychloroquine on skin morphology in psoriasis. J Invest Dermatol 1999; 38: 154-157.
12. Kammer GM, Soter NA, Gibson DJ, Schur PH. Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 1979; 9: 75-97.
13. Baker H. The influence of chloroquine and related drugs on psoriasis and keratoderma blenorrhagicum. Br J Dermatol 1966; 78: 161-166.